Hetero Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OLMESARTAN MEDOXOMIL, with a corresponding US DMF Number 26992.
Remarkably, this DMF maintains an Active status since its submission on March 20, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 02, 2013, and payment made on April 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II